Budczies, J., Schirmacher, P., & Stenzinger, A. (2017). Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types. BioMed Central. https://doi.org/https://doi.org/10.1186/s12920-017-0308-8
Chicago Style (17th ed.) CitationBudczies, Jan, Peter Schirmacher, and Albrecht Stenzinger. Chromosome 9p Copy Number Gains Involving PD-L1 Are Associated with a Specific Proliferation and Immune-modulating Gene Expression Program Active Across Major Cancer Types. London: BioMed Central, 2017. https://doi.org/https://doi.org/10.1186/s12920-017-0308-8.
MLA (9th ed.) CitationBudczies, Jan, et al. Chromosome 9p Copy Number Gains Involving PD-L1 Are Associated with a Specific Proliferation and Immune-modulating Gene Expression Program Active Across Major Cancer Types. BioMed Central, 2017. https://doi.org/https://doi.org/10.1186/s12920-017-0308-8.